Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LiFT: LPCN 1144 in Men with NASH
NCT04134091Phase 2Completed
- Sponsor
- Lipocine Inc
- Start
- Aug 2019
- Primary completion
- Jun 2021
- Modality
- Hormone, Biologic
- Countries
- 1
01
Overview
A Phase 2 trial of testosterone undecanoate in Nonalcoholic steatohepatitis (NASH), sponsored by Lipocine Inc. Started Aug 2019; status: completed.
02
Drugs
testosterone undecanoate
03
Conditions
Nonalcoholic steatohepatitis (NASH)
Beyond the preview
Go deeper on NCT04134091.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04134091.